I agree with imprvngmyavg regarding totally wild and wide-eyed optimism on this stock. However, it hard to control such emotions when you truly understand the enormity of what they have, the 20 years of blood, sweat and development, the incredible science behind the drug (Ampion), the dozens of applications of the technology way above and beyond OA, the huge pipeline of other equally exciting drugs and their applications, etc. etc. When one looks at SRPT and sees what happened there, in comparison these "wild" predictions just may not be so wild after all. I truly hesitate to get too excited and try not to buy in too much - or get my hopes up too high - but it is very difficult when you truly understand what is behind it all and how it all works. Sometime, just sometimes, these things actually do come to fruition. I happen to think this is one of those times. - and have 100,000+ shares banking on it.
My disagreement is that there is wild eyed optimism. You ignore lots who think it will fail. Lets try realistic loking at AMPE and it only one of their drugs comes to fruition then AMPE is worth several times the current $6. The would also make the shorts cover and add $4-$6 in a few days.